In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dow Chemical Co.

www.dow.com

Latest From Dow Chemical Co.

Purell Battling Class Actions Over Disease Claims While World Scrambles To Increase Hand Sanitizer Supplies

Leading chemical firms, beauty and consumer health companies, even distilleries and medical marijuana cultivators are adapting operations to meet global demand for hand sanitizers amid the COVID-19 pandemic. Meanwhile, plaintiff’s attorneys are busy with multiple class actions against Purell manufacturer GOJO Industries for alleged false advertising following a January warning letter to the firm from the US FDA.

United States Legal Issues

FDA Warning Letter Renews Concerns About Barring Inspection Photos

An FDA warning letter issued in August to OTC drug manufacturer Homeolab has revived discussion about companies' options when it comes to investigator photographs during facility inspections, prompting fresh insight from industry attorneys on the issue's legal underpinning and existing case law.

Legal Issues Regulation

Preservative Innovation Competition Will Launch Imminently, GC3 Says

Leading personal-care firms are hopeful that early-stage innovators won’t be the only winners in a competition launching within weeks to identify promising new preservative technologies. Entrants can walk away with a prize of $25,000 or more, but the real draw is the opportunity to partner with a corporate sponsor.

Research & Development Cosmetic Ingredients

Industry Roundup: DXM Bill Moves, CHPA Biz Dev VP, Neurobrands Injunction

House subcommittee approves DXM Abuse bill; UK ire for US firm’s patch claims; Innophos VP hire; and more news in brief.

Dietary Supplements Wellness
See All

Company Information

UsernamePublicRestriction

Register